Understanding the link between neurotropic viruses, BBB permeability, and MS pathogenesis

Area of Science:

• Neurovirology
• Immunology
• Neurology

Background:

• Neurotropic viruses can invade the central nervous system (CNS) by compromising the blood-brain barrier (BBB).
• Viral proteins directly interact with tight junctions (TJs) of brain microvascular endothelial cells (BMECs), disrupting BBB integrity.
• This BBB disruption is implicated in various neurological diseases, including multiple sclerosis (MS).

Purpose of the Study:

• To review the mechanisms by which neurotropic viruses breach the BBB.
• To explore the association between viral infections, BBB dysfunction, and the pathogenesis of MS.
• To identify potential therapeutic targets based on these viral-BBB-MS interactions.

Main Methods:

• Literature review of studies on neurotropic viruses and BBB.
• Analysis of viral protein interactions with TJ proteins (e.g., claudins, ZO-1).
• Examination of molecular mimicry between viral antigens and myelin proteins in MS pathogenesis.
• Review of viral models for experimental autoimmune encephalomyelitis (EAE).

Main Results:

• Neurotropic viruses like HIV-1, JEV, HSV-1, EBV, and MAV-1 utilize various mechanisms to cross the BBB.
• Specific viral proteins (e.g., HIV-1 Tat) downregulate TJ proteins, increasing BBB permeability.
• Molecular mimicry between viral proteins (e.g., EBNA1) and myelin proteins (e.g., MBP) can trigger autoimmune responses relevant to MS.
• Viral infections are linked to BBB leakiness and MS, with EAE models providing insights.

Conclusions:

• Neurotropic viruses contribute to BBB dysfunction and neurological diseases, notably MS.
• Viral-induced BBB disruption and molecular mimicry are key pathogenic mechanisms.
• Further research into these mechanisms may reveal novel therapeutic strategies for MS and other neuroinflammatory conditions.